Series date: 
01/01/2025 - 12:00pm CST to 12/31/2025 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Apply NCCN guidelines when treating cancer patients.
2. Identify evidence-based timing of surgical intervention amongst the metastatic patient population
3. Continuously introduce new treatment modalities as appropriate
4. Contribute to and help formulate the best treatment plan for patient's cases discussed

PLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Coral.Fraire@BSWHealth.org 

 

Series location: 
Baylor Scott & White Medical Center - Temple
2401 S 31st Street
Temple, TX 76508
United States
See map: Google Maps

Sessions

Session Date
20250116 Temple Pathology JC - Artificial Intelligence in Melanoma Dermatopathology: A Review of Literature 01/16/2025 - 12:00pm to 1:00pm CST
20250206 Temple Pathology JC - Fetal and Perinatal Brain Autopsy: Useful Macroscopic Techniques Including Agar In-situ and Pre-Embedding Methods And Perfusion fixation in brain banking: a systematic review 02/06/2025 - 12:00pm to 1:00pm CST
20250313 Temple Pathology JC -Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation 03/13/2025 - 12:00pm to 1:00pm CDT
20250403 Temple Pathology JC -Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells 04/03/2025 - 12:00pm to 1:00pm CDT
20250501 Temple Pathology JC- Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling 05/01/2025 - 12:00pm to 1:00pm CDT
20250605 Temple Pathology JC - Confocal Laser Microscopy for Intraoperative Margin Assessment in Breast-Conserving Surgery 06/05/2025 - 12:00pm to 1:00pm CDT
20250710 Temple Pathology JC Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis 07/10/2025 - 12:00pm to 1:00pm CDT
20250807 Temple Pathology JC- Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry 08/07/2025 - 12:00pm to 1:00pm CDT
20250904 Temple Pathology JC- Applications of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections 09/04/2025 - 12:00pm to 1:00pm CDT
YYYYMMDD Temple Pathology JC 10/02/2025 - 12:00pm to 1:00pm CDT

Pages